Raul Santos, MD, PhD

Raul Santos Filho

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: AMGEN(SIGNIFICANT), Kowa(MODEST), Sanofi/Regeneron(SIGNIFICANT), Novo-Nordisk(MODEST), Ache(MODEST), PTC(MODEST), Novartis Corporation(MODEST) SPEAKER'S BUREAU: Amryt(MODEST), Biolab(MODEST), Eli Lilly and Company(MODEST), Libbs (SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Esperion(MODEST)

View Full Disclosure